Home
Clinical Resources Search
PQI: Olanzapine (Zyprexa®) In Chemotherapy Induced Nausea and Vomiting

Olanzapine (Zyprexa®) In Chemotherapy Induced Nausea and Vomiting

Last Updated: November 13, 2023

By: Julianne Darling, PharmD

About this PQI

This PQI will examine the use of olanzapine (Zyprexa®) in the treatment of chemotherapy induced nausea and vomiting (CINV).

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.

Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Frequently Searched

Supported by

Olanzapine (Zyprexa®) In Chemotherapy Induced Nausea and Vomiting

About this PQI

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Sutimlimab-jome (Enjaymo) for the Management of Hemolysis in Cold Agglutinin Disease (CAD)

PQI: Datopotamab deruxtecan (DATROWAY): Prophylaxis and Management of Adverse Events

PQI: Eflapegrastim-xnst (Rolvedon) for Chemotherapy-Induced Neutropenia

PQI: Revumenib (Revuforj) for the Management of Acute Leukemia

PQI in Action: Epcoritamab (Epkinly) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

PQI in Action: Nirogacestat (Ogsiveo) use in Management of Adults with Progressing Desmoid Tumors (or fibromatosis or aggressive fibromatosis)

PQI in Action: Abiraterone acetate (Yonsa) Patient Selection and Management

PQI in Action: Enfortumab Vedotin-ejfv (Padcev®) and Pembrolizumab (Keytruda®) Management for Advanced or Metastatic Urothelial Carcinoma

S9 E9: The Realities of Ethics in Oncology

S9 E8: Mental Strength at Work

S9 E7: A Haven of Healing

S9 E6: Healing Through Sound: A Breast Cancer Journey

Readiness Tracker

Treatment Support Kit: Elranatamab

Treatment Support Kit: Mirdametinib

Treatment Support Kit: Abemaciclib

Treatment Support Kit: Temozolomide

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Understanding Nausea and Vomiting During Cancer Treatment

PQI: Sacituzumab govitecan-hziy (Trodelvy®): Prophylaxis and Management of Adverse Events

PQI: Granisetron Transdermal System (Sancuso®) for Chemotherapy Induced Nausea and Vomiting

PQI: Chemotherapy-Induced Nausea and Vomiting

PQI: Netupitant/Fosnetupitant and Palonosetron (Akynzeo®) for Chemotherapy-Induced Nausea and Vomiting

Daratumumab and KRd

Daratumumab and VRd

Taletrectinib

PQI: Datopotamab deruxtecan (DATROWAY): Prophylaxis and Management of Adverse Events